Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia.

The Journal of antimicrobial chemotherapy - 1 Feb 2024

Ertl Nicole G, Anderson Taylah K, Pardo Carolyn J, Maidment Toby I, Murray Gerald L, Bradshaw Catriona S, Whiley David M, Sweeney Emma L

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Australia
Share to DNA Gyrase
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluoroquinolones

Share to Macrolides

Share to Mycoplasma genitalium

Share to Mycoplasma Infections

Share to Queensland

Source

Open in PubMed Open full text

Identifiers

PMID: 38102067
DOI: 10.1093/jac/dkad373
PMCID: PMC10832590

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia.PMID 38102067Read ↗

Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistanceSemantic proximity Read ↗

Mycoplasma genitalium infections can comprise a mixture of both fluoroquinolone-susceptible and fluoroquinolone-resistant strains.Semantic proximity Read ↗

Prevalence of Mycoplasma genitalium fluoroquinolone-resistance markers, and dual-class-resistance markers, in asymptomatic men who have sex with men.Semantic proximity Read ↗

Molecular Characterization and Detection of Macrolide and Fluoroquinolone Resistance Determinants in Mycoplasma genitalium in South Africa, 2015 to 2018.Semantic proximity Read ↗

Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.Semantic proximity Read ↗

Detection of markers predictive of macrolide and fluoroquinolone resistance in Mycoplasma genitalium from patients attending sexual health services.Semantic proximity Read ↗

Frequency and Correlates of Mycoplasma genitalium Antimicrobial Resistance Mutations and Their Association With Treatment Outcomes: Findings From a National Sentinel Surveillance Pilot in England.Semantic proximity Read ↗

Antimicrobial resistance in Mycoplasma genitalium sampled from the British general populationSemantic proximity Read ↗

Genomic characterisation of Mycoplasma genitalium in Victoria, Australia, reveals lineage diversification and drivers of antimicrobial resistance.Semantic proximity Read ↗

Prevalence of fluoroquinolone resistance-associated mutations in Mycoplasma genitalium among clients of two sexual health centres in the Netherlands: a cross-sectional study.Semantic proximity Read ↗

gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy.Semantic proximity Read ↗

The association between antimicrobial resistance mutations and treatment outcomes for Mycoplasma genitalium infections from 2018 to 2022: a cross-sectional study from Auckland, New Zealand.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.